Klaus Klaushofer

Hanusch Hospital — Austria

Medicine · Health Sciences

53h-index12.0kcitations325works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and osteoporosis research(93), Bone health and treatments(91), Connective tissue disorders research(62), Bone Metabolism and Diseases(48), Parathyroid Disorders and Treatments(33)

Publications324 total

Treatment of postmenopausal osteoporosis patients with teriparatide for 24 months reverts forming bone quality indices to premenopausal healthy control values
Bone·2022· 5 cited
Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption
eLife·2021· 23 citedOpen Access
Author response: Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption
2021Open Access
Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption
2021· 1 citedOpen Access
The doubled burden of diabetic bone disease: hip fracture and post-hip fracture mortality
European Journal of Endocrinology·2021· 15 citedOpen Access
Mineral and organic matrix composition at bone forming surfaces in postmenopausal women with osteoporosis treated with either teriparatide or zoledronic acid
Bone·2021· 10 citedOpen Access
New Ifitm5 S42L mouse model for atypical type VI OI connects types V and VI Osteogenesis Imperfecta
Bone Reports·2020· 1 citedOpen Access
Alterations of bone material properties in adult patients with X-linked hypophosphatemia (XLH)
Journal of Structural Biology·2020· 36 cited
Somatic <i>SMAD3</i>-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway
The Journal of Experimental Medicine·2020· 42 citedOpen Access
Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk After Hip Fracture
Journal of Crohn s and Colitis·2020· 18 cited
No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients
Bone Reports·2020· 10 citedOpen Access
Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia
Matrix Biology·2020· 19 citedOpen Access
Bone tissue characterization of a mouse model of atypical type VI osteogenesis imperfecta reveals hypermineralization of the bone matrix, elevated osteocyte lacunar density and altered vascularity
Osteologie/Osteology·2020
Newly formed and remodeled human bone exhibits differences in the mineralization process
Acta Biomaterialia·2020· 43 cited
Basic Aspects of Bone Mineralization
Contemporary Endocrinology·2020· 5 cited
Osteoporosis Therapeutics 2020
Handbook of experimental pharmacology·2020· 21 cited
Impact Microindentation Assesses Periosteal Bone Matrix Quality in Humans
Data Archiving and Networked Services (DANS)·2019
Impact microindentation assesses subperiosteal bone material properties in humans
Bone·2019· 18 cited
Treatment Effects of Bisphosphonates and Denosumab on Survival and Refracture from Real-World Data of Hip-Fractured Patients
Calcified Tissue International·2019· 29 cited
Material properties and osteoporosis
F1000Research·2019· 8 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Paul Roschger(36), Peter Fratzl(22), Eleftherios P. Paschalis(17), Nadja Fratzl‐Zelman(12), Frank Rauch(10), David W. Dempster(8), Francis H. Glorieux(8), Sonja Gamsjaeger(7), Barbara M. Misof(6), Elizabeth Shane(5), Felicia Cosman(4), Jeri W. Nieves(4), Michael P. Whyte(4), Roger Phipps(4), Robert R. Recker(4), Andreas Roschger(4), Wolfgang Wagermaier(4), David B. Burr(3), Bo Abrahamsen(3), Robert A. Adler(3)